Kolexia
Mohammedi Mohammed Kamel Endocrinologie
Mohammedi Mohammed Kamel
Endocrinologie
Hôpital Haut-lévêque
Pessac, France
221 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 2 Diabète de type 1 Diabète Néphropathies diabétiques Maladies du rein Rétinopathie diabétique Maladie artérielle périphérique Angiopathies diabétiques Obésité

Collaborateurs

Voir plus
Rigalleau Vincent
Rigalleau Vincent
Hôpital Haut-lévêque, Pessac, France
Marre Michel
Marre Michel
Cmc Ambroise Pare Hartmann Site 48 Ter, Neuilly-sur-Seine, France
Blanco-Baillet Laurence
Blanco-Baillet Laurence
Hôpital Haut-lévêque, Pessac, France
Foussard Ninon
Foussard Ninon
CHU Bordeaux, Bordeaux, France

Industries

Voir plus
Lilly
17 collaboration(s)
Dernière en 2022
AstraZeneca
13 collaboration(s)
Dernière en 2021
Sanofi
12 collaboration(s)
Dernière en 2023
Novo Nordisk
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
European journal of endocrinology   07 mars 2024
Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study.
European heart journal   01 mars 2024
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Diabetes & metabolism   11 février 2024
Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia.
Cardiovascular revascularization medicine : including molecular interventions   01 février 2024
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.
Cardiovascular diabetology   13 janvier 2024
Incidence of stroke and clinical outcomes in people with type 2 diabetes: A real-world database study in France
JESFC 2024   01 janvier 2024
SCADIAB: Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes at Very High Cardiovascular Risk: Target Trial Emulation From the National Healthcare System Claims Databases in France
Essai Clinique (CHU Bordeaux)   29 décembre 2023
Comment on Peker, T.; Boyraz, B. The Relationship between Resistant Hypertension and Advanced Glycation End-Product Levels Measured Using the Skin Autofluorescence Method: A Case-Control Study. 2023, , 6606.
Journal of clinical medicine   08 décembre 2023
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records.
Cardiovascular diabetology   28 novembre 2023
More new cancers in type 2 diabetes with diabetic foot disease: A longitudinal observational study.
Diabetes & metabolic syndrome   27 septembre 2023